These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 24553870)

  • 1. Induced pluripotent stem cells and neurological disease models.
    Cai S; Chan YS; Shum DK
    Sheng Li Xue Bao; 2014 Feb; 66(1):55-66. PubMed ID: 24553870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery.
    Corti S; Faravelli I; Cardano M; Conti L
    Expert Opin Drug Discov; 2015 Jun; 10(6):615-29. PubMed ID: 25891144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling human neurological disorders with induced pluripotent stem cells.
    Imaizumi Y; Okano H
    J Neurochem; 2014 May; 129(3):388-99. PubMed ID: 24286589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling neurological diseases using iPSC-derived neural cells : iPSC modeling of neurological diseases.
    Li L; Chao J; Shi Y
    Cell Tissue Res; 2018 Jan; 371(1):143-151. PubMed ID: 29079884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced pluripotent stem cells for modeling of pediatric neurological disorders.
    Jang J; Quan Z; Yum YJ; Song HS; Paek S; Kang HC
    Biotechnol J; 2014 Jul; 9(7):871-81. PubMed ID: 24838856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced pluripotent stem cells: a new revolution for clinical neurology?
    Mattis VB; Svendsen CN
    Lancet Neurol; 2011 Apr; 10(4):383-94. PubMed ID: 21435601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using induced pluripotent stem cell neuronal models to study neurodegenerative diseases.
    Zhang X; Hu D; Shang Y; Qi X
    Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165431. PubMed ID: 30898538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced pluripotent stem cells: opportunities as research and development tools in 21st century drug discovery.
    Rowntree RK; McNeish JD
    Regen Med; 2010 Jul; 5(4):557-68. PubMed ID: 20632859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neural Stem Cells Derived from Human-Induced Pluripotent Stem Cells and Their Use in Models of CNS Injury.
    Jendelova P; Sykova E; Erceg S
    Results Probl Cell Differ; 2018; 66():89-102. PubMed ID: 30209655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced pluripotent stem cells in the study of neurological diseases.
    Saporta MA; Grskovic M; Dimos JT
    Stem Cell Res Ther; 2011 Sep; 2(5):37. PubMed ID: 21936964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells.
    Mungenast AE; Siegert S; Tsai LH
    Mol Cell Neurosci; 2016 Jun; 73():13-31. PubMed ID: 26657644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human stem cells for modeling neurological disorders: accelerating the drug discovery pipeline.
    Crook JM; Kobayashi NR
    J Cell Biochem; 2008 Dec; 105(6):1361-6. PubMed ID: 18980214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D brain Organoids derived from pluripotent stem cells: promising experimental models for brain development and neurodegenerative disorders.
    Lee CT; Bendriem RM; Wu WW; Shen RF
    J Biomed Sci; 2017 Aug; 24(1):59. PubMed ID: 28822354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced pluripotent stem cells (iPSCs) and neurological disease modeling: progress and promises.
    Marchetto MC; Brennand KJ; Boyer LF; Gage FH
    Hum Mol Genet; 2011 Oct; 20(R2):R109-15. PubMed ID: 21828073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced pluripotent stem cell research: a revolutionary approach to face the challenges in drug screening.
    Song M; Paul S; Lim H; Dayem AA; Cho SG
    Arch Pharm Res; 2012 Feb; 35(2):245-60. PubMed ID: 22370779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cell contributions to neurological disease modeling and personalized medicine.
    Liang N; Trujillo CA; Negraes PD; Muotri AR; Lameu C; Ulrich H
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt A):54-62. PubMed ID: 28576415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug discovery using induced pluripotent stem cell models of neurodegenerative and ocular diseases.
    Hung SSC; Khan S; Lo CY; Hewitt AW; Wong RCB
    Pharmacol Ther; 2017 Sep; 177():32-43. PubMed ID: 28223228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced Pluripotency: A Powerful Tool for In Vitro Modeling.
    Zahumenska R; Nosal V; Smolar M; Okajcekova T; Skovierova H; Strnadel J; Halasova E
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remodeling neurodegeneration: somatic cell reprogramming-based models of adult neurological disorders.
    Qiang L; Fujita R; Abeliovich A
    Neuron; 2013 Jun; 78(6):957-69. PubMed ID: 23791192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.